Samsung Biologics to launch $1.8 billion all-cash bid for PolyPeptide
South Korea's Samsung Biologics will launch a 1.46 billion Swiss francs ($1.81 billion) all-cash bid for Swiss contract drugmaker PolyPeptide, the companies said in separate
July 20, 2026
France commemorates the Vel d’Hiv roundup after a Paris plaque honoring rescuers is vandalized
UK chief financial officers turn more hopeful about AI
Samsung Biologics to launch $1.8 billion all-cash bid for PolyPeptide
TSMC expects 'strong, multi-year' demand for AI chips as it ramps up Arizona investment
Soccer-Spain unites in joy at second World Cup crown
Why Spain’s homage to 2010 and 2024 was the right ending for one of the best World Cups ever
Soccer-Substitute Torres rescues grim final to make Spain world champions